MedTech Europe’s Reaction to the European Commission’s Proposal for amending the IVD Regulation
Posted on 14.10.2021
MedTech Europe takes note of today’s proposal to amend to the In Vitro Diagnostic Medical Devices Regulation issued by the European Commission.
It is important that the European Commission seeks to safeguard the availability of in vitro diagnostic tests to patients and healthcare systems, particularly in a challenging pandemic situation, while transitioning into the Regulation.
MedTech Europe and its members remain fully committed to the goals of the Regulation and its implementation.
All parties will now have to assess if the suggested amendments address the critical implementation challenges at stake for an efficient and successful transition.